310
Views
4
CrossRef citations to date
0
Altmetric
Articles

A split face comparative study between intradermal tranexamic acid and Erbium-YAG laser in treatment of melasma

, , , , ORCID Icon, & show all
Pages 555-559 | Received 07 May 2020, Accepted 14 May 2020, Published online: 04 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fatemeh Mokhtari, Bahareh Bahrami, Gita Faghihi, Ali Asilian & Fariba Iraji. (2022) Fractional erbium:YAG laser (2940 nm) plus topical hydroquinone compared to intradermal tranexamic acid plus topical hydroquinone for the treatment of refractory melasma: a randomized controlled trial. Journal of Dermatological Treatment 33:5, pages 2475-2481.
Read now

Articles from other publishers (3)

Hailey Konisky, Eliza Balazic, Jose A. Jaller, Urmi Khanna & Kseniya Kobets. (2023) Tranexamic acid in melasma: A focused review on drug administration routes. Journal of Cosmetic Dermatology 22:4, pages 1197-1206.
Crossref
Aysenur Botsali, Pelin Esme, Hakan Erbil & Ercan Caliskan. (2022) Comparison of fractional erbium:YAG laser-assisted tranexamic acid delivery alone and in combination with oral tranexamic acid in melasma. Lasers in Medical Science 37:7, pages 2823-2830.
Crossref
Maryam Nasimi, Maryam Ghiasi, Vahideh Lajevardi, Fatemeh Nasiri & Safoura Shakoei. (2021) A split-face comparison of fractional erbium: YAG laser plus Kligman’s formula vs. Kligman’s formula monotherapy for facial melasma. Archives of Dermatological Research 314:8, pages 791-797.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.